Product formulations and in vitro-in vivo evaluation of a novel "Tablet-in-a-Bottle" suspension formulation of amoxicillin and clavulanic acid Public Deposited

http://ir.library.oregonstate.edu/concern/graduate_thesis_or_dissertations/4x51hm327

Descriptions

Attribute NameValues
Creator
Abstract or Summary
  • This thesis describes a novel "Tablet-in-a-Bottle" oral suspension formulation. Ingredients with unstable physical or chemical characteristics can be placed in a core tablet, and then dry compression coated with an outer layer which provides separation from other components. The new suspension formulation comprises fast disintegrating clavulanic acid (KCA) tablets with a powder mixture containing amoxicillin. Hardness, friability, flow properties and weight uniformity of tablets for three different formulations were investigated and were all improved in a third formulation. Stability tests under different humidities were conducted. Amoxicillin and clavulanic acid in the new formulations showed the same stabilities when compared with the marketed product Augmentin®. Preliminary pharmacokinetics and bioavailability of one new formulation were evaluated by comparing in vitro release rates and in vivo urinary excretion rates. In vitro dissolution studies were carried out according to the USP XXIII paddle method. The new formulation showed faster release rates during the first hour when stirring speed was 25 rpm. However, when 75 rpm stirring speed was applied, the dissolution profiles for the new formulation and the reference marketed product were identical. A randomized two-way crossover bioequivalence study was designed to evaluate the bioavailabilities. Cmax, Tmax and AUC[subscript o--->t] of amoxicillin were within ±20% of the reference pharmacokinetic values. However, Cmax and Tmax of clavulanate were not within ±20%. Bioeqivalence between this new suspension formulation and the marketed product (Augmentin®) were evaluated using a two one-sided t-test. There is not sufficient statistical support with this test to conclude that the two products are bioequivalent. However, this is most likely due to small sample size and high intersubject variation and statistical support for bioequivalence is expected in a larger study group.
Resource Type
Date Available
Date Copyright
Date Issued
Degree Level
Degree Name
Degree Field
Degree Grantor
Commencement Year
Advisor
Academic Affiliation
Non-Academic Affiliation
Subject
Rights Statement
Peer Reviewed
Language
Digitization Specifications
  • File scanned at 300 ppi (Monochrome, 256 Grayscale, 24-bit Color) using Capture Perfect 3.0 on a Canon DR-9050C in PDF format. CVista PdfCompressor 4.0 was used for pdf compression and textual OCR.
Replaces
Additional Information
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2012-09-20T17:16:38Z (GMT) No. of bitstreams: 1 YangNingNing1998.pdf: 4896477 bytes, checksum: 4946d085d880f85aa519f85780ee6a01 (MD5)
  • description.provenance : Approved for entry into archive by Patricia Black(patricia.black@oregonstate.edu) on 2012-09-20T17:21:39Z (GMT) No. of bitstreams: 1 YangNingNing1998.pdf: 4896477 bytes, checksum: 4946d085d880f85aa519f85780ee6a01 (MD5)
  • description.provenance : Submitted by Kirsten Clark (kcscannerosu@gmail.com) on 2012-09-19T21:29:07Z No. of bitstreams: 1 YangNingNing1998.pdf: 4896477 bytes, checksum: 4946d085d880f85aa519f85780ee6a01 (MD5)
  • description.provenance : Made available in DSpace on 2012-09-20T17:21:39Z (GMT). No. of bitstreams: 1 YangNingNing1998.pdf: 4896477 bytes, checksum: 4946d085d880f85aa519f85780ee6a01 (MD5) Previous issue date: 1997-06-11

Relationships

Parents:

This work has no parents.

Last modified

Downloadable Content

Download PDF

Items